Norway
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
19.92%
|
Dec. 31, 2023 | USD 14.13 | 1.11% |
|
Norway |
|
2 |
16.33%
|
Dec. 31, 2023 | USD 1.26 | -2.20% |
|
Norway |
|
3 |
0.65%
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
4 |
0.20%
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
5 |
-7.82%
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
6 |
-269.43%
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
7 |
-272.47%
|
Dec. 31, 2023 | USD 0.23 | -0.24% |
|
Norway |
|
8 |
-679.43%
|
Dec. 31, 2023 | USD 0.11 | -0.62% |
|
Norway |
|
9 |
-53,785.59%
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
The Healthcare company in Norway with the highest Net Income Margin is Medistim ASA (Oslo Stock Exchange: MEDI.OL) at 19.92%.
The Healthcare company in Norway with the lowest Net Income Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -53,785.59%.
The top 10 Healthcare companies in Norway by Net Income Margin are Medistim ASA, ArcticZymes Technologies ASA, Navamedic ASA, Photocure ASA, Gentian Diagnostics ASA, Lifecare AS, Nykode Therapeutics AS, PCI Biotech Holding ASA and BerGenBio ASA.
The bottom 10 Healthcare companies in Norway by Net Income Margin are BerGenBio ASA, PCI Biotech Holding ASA, Nykode Therapeutics AS, Lifecare AS, Gentian Diagnostics ASA, Photocure ASA, Navamedic ASA, ArcticZymes Technologies ASA and Medistim ASA.